The main recognized risk factors for the development of ILD in RA include male sex, older age, late disease onset, duration of RA, tobacco exposure, moderate or high sustained RA activity, seropositivity for RF and/or ACPA, and polymorphisms in the MUC5B gene [4,7,15,22,28]. Here, PRTN3 is linked to interstitial lung disease.